Movement Alert｜Giant Biogene Rises 6.43% in Regular Trading, 618 Promotion Results Beat Expectations Amid Sector-Wide Strength

Market Focus06-29 13:02

On June 29, Giant Biogene (02367.HK) rose 6.43% in regular trading, trading at HKD 27.48/share, with turnover of HKD 85.81 million. The rally was driven by better-than-expected 618 promotion results and broad strength across the personal products sector.

The company recently disclosed its 618 shopping festival performance: its core brand Kefumei achieved online omni-channel GMV growth of over 25% year-over-year, while Kelikin recorded full-cycle GMV growth exceeding 30% YoY. Notably, Kefumei successfully reversed a declining trend from the same period last year. Multiple brokerages maintain Buy or Outperform ratings, citing improving fundamentals and medical aesthetics commercialization progress.

The personal products sector rallied broadly, with CHICMAX up 15.17%, MAO GEPING up 8.4%, and SOFTCARE up 3.85%. Giant Biogene's medical aesthetics pipeline, including its recently approved crosslinked recombinant collagen filler for neck wrinkles — the world's first such product — continues to attract institutional attention as commercialization commenced in early June.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1124340855?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 13:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124340855","market":"us","top_or_hot":-1,"title":"Movement Alert｜Giant Biogene Rises 6.43% in Regular Trading, 618 Promotion Results Beat Expectations Amid Sector-Wide Strength","media":"Market Focus","content":"<p><p>On June 29, Giant Biogene (02367.HK) rose 6.43% in regular trading, trading at HKD 27.48/share, with turnover of HKD 85.81 million. The rally was driven by better-than-expected 618 promotion results and broad strength across the personal products sector.</p><p>The company recently disclosed its 618 shopping festival performance: its core brand Kefumei achieved online omni-channel GMV growth of over 25% year-over-year, while Kelikin recorded full-cycle GMV growth exceeding 30% YoY. Notably, Kefumei successfully reversed a declining trend from the same period last year. Multiple brokerages maintain Buy or Outperform ratings, citing improving fundamentals and medical aesthetics commercialization progress.</p><p>The personal products sector rallied broadly, with CHICMAX up 15.17%, MAO GEPING up 8.4%, and SOFTCARE up 3.85%. Giant Biogene's medical aesthetics pipeline, including its recently approved crosslinked recombinant collagen filler for neck wrinkles — the world's first such product — continues to attract institutional attention as commercialization commenced in early June.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Giant Biogene Rises 6.43% in Regular Trading, 618 Promotion Results Beat Expectations Amid Sector-Wide Strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Giant Biogene Rises 6.43% in Regular Trading, 618 Promotion Results Beat Expectations Amid Sector-Wide Strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-29 13:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 29, Giant Biogene (02367.HK) rose 6.43% in regular trading, trading at HKD 27.48/share, with turnover of HKD 85.81 million. The rally was driven by better-than-expected 618 promotion results and broad strength across the personal products sector.</p><p>The company recently disclosed its 618 shopping festival performance: its core brand Kefumei achieved online omni-channel GMV growth of over 25% year-over-year, while Kelikin recorded full-cycle GMV growth exceeding 30% YoY. Notably, Kefumei successfully reversed a declining trend from the same period last year. Multiple brokerages maintain Buy or Outperform ratings, citing improving fundamentals and medical aesthetics commercialization progress.</p><p>The personal products sector rallied broadly, with CHICMAX up 15.17%, MAO GEPING up 8.4%, and SOFTCARE up 3.85%. Giant Biogene's medical aesthetics pipeline, including its recently approved crosslinked recombinant collagen filler for neck wrinkles — the world's first such product — continues to attract institutional attention as commercialization commenced in early June.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02367","symbol_name":"巨子生物","start_time":0,"source_url":"","article_id":"1124340855","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124340855","pubTimestamp":1782709370,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 29, Giant Biogene (02367.HK) rose 6.43% in regular trading, trading at HKD 27.48/share, with turnover of HKD 85.81 million. The rally was driven by better-than-expected 618 promotion results...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02367":"巨子生物"},"translate_title":"动感快讯|巨人生物基因常规盘涨6.43%全板块走强下618促销成绩超预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02367":1},"content_text":"On June 29, Giant Biogene (02367.HK) rose 6.43% in regular trading, trading at HKD 27.48/share, with turnover of HKD 85.81 million. The rally was driven by better-than-expected 618 promotion results and broad strength across the personal products sector.The company recently disclosed its 618 shopping festival performance: its core brand Kefumei achieved online omni-channel GMV growth of over 25% year-over-year, while Kelikin recorded full-cycle GMV growth exceeding 30% YoY. Notably, Kefumei successfully reversed a declining trend from the same period last year. Multiple brokerages maintain Buy or Outperform ratings, citing improving fundamentals and medical aesthetics commercialization progress.The personal products sector rallied broadly, with CHICMAX up 15.17%, MAO GEPING up 8.4%, and SOFTCARE up 3.85%. Giant Biogene's medical aesthetics pipeline, including its recently approved crosslinked recombinant collagen filler for neck wrinkles — the world's first such product — continues to attract institutional attention as commercialization commenced in early June.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124340855","isCrawlerRequest":true}